SLC39A6 Knockout Cell Line (HEK 293)

Yes. ZIP6 rescue experiments require attention to ZIP10 heterodimer biology: • Construct design: use a codon-modified SLC39A6 sequence with a small C-terminal tag (FLAG, HA). ZIP6 has 8 transmembrane domains — N-terminal tags after the signal peptide are tolerated. • ZIP10 partnership: ZIP6 and ZIP10 form heterodimers; rescue interpretation should consider ZIP10 expression in HEK293. • Transport-deficient rescue: histidine-rich loop mutations or transmembrane zinc-binding residue mutations enable structure-function studies. • Functional readout: rescue should restore zinc uptake activity (FluoZin-3 imaging) and downstream EMT-related phenotypes where relevant. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

Primary applications: • Cellular zinc uptake: zinc-sensitive fluorescent probes (FluoZin-3, ZinPyr-1) or ICP-MS to quantify ZIP6-dependent zinc influx. • EMT phenotype analysis: epithelial/mesenchymal marker expression, migration assays given ZIP6's reported EMT-promoting function. • Breast cancer biology: studies of ZIP6 estrogen regulation and tumor-promoting activity in cancer contexts. • Anti-LIV-1 ADC specificity: critical genetic control for ladiratuzumab vedotin and related ZIP6/LIV-1-targeting ADCs in development. EDITGENE recommends this model for researchers investigating zinc transport biology, breast cancer EMT mechanisms, and ZIP6-targeted therapeutics.

The choice depends on whether you are studying SLC39A6 (ZIP6/LIV-1)'s role in zinc uptake or its emerging functions in epithelial-mesenchymal transition (EMT) and cancer biology. The Knockout line is appropriate for asking whether ZIP6 is required for cellular zinc influx — particularly relevant in breast cancer contexts where ZIP6 is estrogen-regulated and associated with tumor progression. Overexpression is useful for studying ZIP6 in EMT and cancer phenotypes. For ZIP6 research, the EDITGENE Knockout in HEK293 is a mechanistic platform for zinc transport biology and EMT mechanism studies. ZIP family compensation should be assessed (ZIP10 is the closest paralog and forms heterodimers with ZIP6). Rescue with wild-type or transport-deficient ZIP6 enables structure-function studies. ZIP6 is also a target for ADC development (ladiratuzumab vedotin) — the knockout serves as a specificity control.